In April 2017, we published a blog with crucial information about EpiPen and EpiPen Jr Recalls. Recently the U.S. Food and Drug Administration (FDA) accused Meridian Medical Technologies, Inc., a Pfizer medical company that produces EpiPens, of failing to investigate hundreds of complaints that the life-saving anti-allergy device (commonly known as an EpiPen) misfired during emergency situations.
In a letter addressed to Meridian’s President and General Manager the FDA stated the following:
“Among other things, you manufacture two epinephrine auto-injectors at your facility, EpiPen and EpiPen Jr., (collectively, EpiPen products). These products are intended to deliver a lifesaving drug (epinephrine) during emergency treatment of serious allergic reactions, including anaphylaxis. If your auto-injectors do not operate as expected and deliver the intended amount of epinephrine drug when deployed in emergencies, patients can die or suffer serious illness. You failed to thoroughly investigate multiple serious component and product failures for your EpiPen products, including failures associated with patient deaths and severe illness. You also failed to expand the scope of your investigations into these serious and life-threatening failures or take appropriate corrective actions, until FDA’s inspection.”
When a manufacturer fails to put safety first we’ll hold them accountable. If you or a loved one suffered adverse effects due to a malfunctioning EpiPen or EpiPen Jr. contact us today.
Mr. Finkelstein is the Managing Partner of Finkelstein & Partners, LLP. He has become a noted consumer activist through his representation of injured individuals against corporate wrongdoers and irresponsible parties.
An accomplished litigator, Mr. Finkelstein has represented Plaintiffs in wrongful death and catastrophic personal injury cases. He has successfully handled dozens of multi-million dollar cases.